EcoDrugPlus

Protein Kinase C Beta Type

Ensembl ID : ENSAMXG00000011950
Gene Symbol: LOC103025973
3 Cross references
159 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSAMXG00000016004
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSAMXG00000000041
Gene Symbol: PRKCE
1 Cross references
251 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSAMXG00000004336
Gene Symbol: PRKCE
1 Cross references
266 Possible Orthologues:

Protein Kinase C Eta Type

Ensembl ID : ENSAMXG00000019350
Gene Symbol: LOC103034514
3 Cross references
161 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSAMXG00000005889
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase C Zeta Type

Ensembl ID : ENSAMXG00000014051
Gene Symbol: LOC103044996
3 Cross references
205 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSAMXG00000015121
Gene Symbol: PRKCAA
1 Cross references
212 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSAMXG00000002191
Gene Symbol: PRKCDA
1 Cross references
205 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSAMXG00000031671
Gene Symbol: PRKCHA
1 Cross references
216 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSAMXG00000041872
Gene Symbol: PRKD1
3 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSAMXG00000018256
Gene Symbol: PRKD3
4 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).